Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fate Therapeutics (FATE) Other financing activities (2017 - 2024)

Historic Other financing activities for Fate Therapeutics (FATE) over the last 5 years, with Q2 2024 value amounting to -$558000.0.

  • Fate Therapeutics' Other financing activities fell 100000.0% to -$558000.0 in Q2 2024 from the same period last year, while for Mar 2025 it was $62000.0, marking a year-over-year decrease of 9029.73%. This contributed to the annual value of $133000.0 for FY2021, which is N/A changed from last year.
  • Latest data reveals that Fate Therapeutics reported Other financing activities of -$558000.0 as of Q2 2024, which was down 100000.0% from $558000.0 recorded in Q1 2024.
  • In the past 5 years, Fate Therapeutics' Other financing activities ranged from a high of $558000.0 in Q1 2024 and a low of -$558000.0 during Q2 2024